ASHLEY NASWORTHY: Open Payments
NPI 1558009985 · VIDALIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $147 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Insmed, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Grifols USA, LLC | 1 | $32 |
| JAZZ PHARMACEUTICALS INC. | 1 | $30 |
| Verona Pharma, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: NUCALA, Arikayce, Prolastin-C Liquid, XYWAV, Ohtuvayre, BREZTRI, JASCAYD, INSPIRE.
Industry payments across GA — which companies pay providers there.
